Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery
Central Hospital, Nancy, France
176 participants
Jun 1, 2025
OBSERVATIONAL
Conditions
Summary
In 2025, bariatric surgery combined with nutritional and psychological support is one of the most effective treatments for patients with morbid obesity. (2)(3) However, it causes various deficiencies, such as vitamin and iron deficiencies, which justify lifelong personalised vitamin supplementation and, consequently, lifelong medical supervision. The latest recommendations from the French National Authority for Health (Haute Autorité de Santé) clearly state that patients must commit to lifelong medical follow-up after bariatric surgery. (HAS, February 2024, R94). R94. Regular biological monitoring after bariatric surgery is recommended: three times in the first year and then once or twice a year thereafter. Within the OBESEPI cohort (clinical trial number NCT02663388), which comprises patients who underwent surgery at Nancy University Hospital between 2013 and 2018, we observed that over 50% of patients were lost to follow-up five years after surgery.
Eligibility
Inclusion Criteria3
- > Patients included in the OBESEPI cohort;
- Individuals who have received complete information about the organisation of the research and have not objected to their participation and the use of their data;
- Affiliation with a social security scheme.
Exclusion Criteria4
- >Patient who objects to participating in this research;
- Pregnant and breastfeeding women;
- Patients under legal guardianship or curatorship;
- Patients deprived of their liberty by a judicial or administrative decision.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07118540